Clinical Trials Directory

Trials / Unknown

UnknownNCT04661709

Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris

Efficacy and Safety of Chinese Herbal Medicine Wen Xin Granules for the Treatment of Unstable Angina Pectoris With Yang Deficiency and Blood Stasis Syndrome: Study Protocol for a Randomized Controlled Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
502 (estimated)
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a double-blind, randomized placebo-controlled trial which aims to evaluate the efficacy and safety of Wen Xin granule in patients with unstable angina pectoris.

Detailed description

Coronary heart disease has remained the leading cause of death worldwide over the past decades. Unstable angina is a clinical syndrome intermediate in severity between stable angina and acute myocardial infarction with high morbidity and mortality. Standard drug therapy and invasive revascularization are effective in decreasing progression to infarction, reducing symptoms and multiple hospitalizations, in most cases without a decrease in the long-term mortality rate. However, there are still many patients with persistence or recurrence of angina despite standard medical therapy and/or revascularization. Wen Xin granule, as a Chinese herbal medicine has shown great effect in patients with unstable angina in our clinical. However, there is still insufficient evidence on his specific efficacy and safety. Therefor, we'd like to evaluate the efficacy and safety of Wen Xin granule in patients with unstable angina through this multi-center, double-blind, randomized placebo-controlled trial.

Conditions

Interventions

TypeNameDescription
DRUGWen Xin granuleone dose daily, two times per day.
DRUGClopidogrel Hydrogen Sulfate 75 MG Oral Tabletone tablet daily. (for patients who can't use aspirin)
DRUGAtorvastatin Calcium20 mg tablet, one tablet each night.
DRUGIsosorbide Mononitrate Tab 20 MGone tablet, twice daily.
DRUGMetoprolol Tartrate Tab 25 MG12.5 mg or 25 mg, two times daily.
DRUGAspirin Enteric-coated Tablets100mg tablet, one tablet daily.
DRUGWXG placeboone dose daily, two times per day.
DRUGTrimetazidine Dihydrochloride Tablets20 mg tablet, one tablet three times daily.
DRUGglyceryl trinitratebe taken when angina pectoris attacks.

Timeline

Start date
2021-03-01
Primary completion
2023-03-01
Completion
2023-06-01
First posted
2020-12-10
Last updated
2021-01-25

Source: ClinicalTrials.gov record NCT04661709. Inclusion in this directory is not an endorsement.